Kimberly Tableman
About Kimberly Tableman
Kimberly Tableman serves as the Chief Clinical Development Officer at Castor, where she focuses on enhancing patient enrollment and experience in clinical trials. With a background in digital health technologies and leadership roles at various organizations, she is also an author and advocates for women in leadership.
Work at Castor
Kimberly Tableman currently serves as the Chief Clinical Development Officer at Castor, a role she has held since 2021. In this position, she focuses on advancing clinical development initiatives and enhancing the integration of digital health technologies into clinical trials. Her work aims to improve patient enrollment and overall experience in clinical research.
Previous Experience at Rabble Health
Before joining Castor, Kimberly Tableman co-founded Rabble Health, where she held the position of Chief Operating Officer from 2020 to 2021. During her tenure, she led the development and beta launch of a patient engagement platform tailored for Oncology patients. This initiative aimed to improve patient interaction and support in clinical settings.
Background in Pharmaceutical Industry
Kimberly Tableman has extensive experience in the pharmaceutical industry. She worked at GlaxoSmithKline (GSK) from 2017 to 2020 as the Head of Digital Clinical Trials, focusing on the integration of digital health technologies into clinical trials. Prior to that, she served as the Head of Patient Engagement in R&D Tech at GSK. Her career also includes a significant role at Pfizer as Director of Core Process and Technology from 2008 to 2017.
Education and Expertise
Kimberly Tableman holds a Master of Science (M.Sc.) in Information and Knowledge Strategy from Columbia University, which she completed from 2012 to 2013. She also earned a Bachelor of Science in Business Administration with a focus on Management Information Systems from Central Michigan University between 1997 and 1999. Her educational background supports her expertise in clinical development and digital health technologies.
Writing and Community Involvement
In addition to her professional roles, Kimberly Tableman is writing a book aimed at supporting women in leadership, which is scheduled for publication by the end of 2021. She is actively involved in initiatives that transform the clinical research journey, focusing on enhancing patient enrollment and experience in clinical trials.